September 10, 2025Open Access

The Seroprevalence, Risk Factors, and Clinical Profile of Hepatitis D in Patients with Chronic Hepatitis B in Oman: A Multicenter Cross-Sectional Study

View Full Paper

Ask AI

Bookmark

An anti-HDV prevalence of 5.63% was found in patients with chronic HBV infection in Oman, suggesting a need for targeted screening.
The study identified blood transfusions as the main risk factor for anti-HDV positivity, with odds significantly higher for affected individuals.
Only one patient had detectable HDV RNA, indicating that active viremia appears to be rare among this population.
The study utilized a multicenter cross-sectional approach, gathering comprehensive demographic and clinical data to inform risk assessment.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Cross-sectional study shows 5.63% seroprevalence of hepatitis D in chronic hepatitis B patients, highlighting blood transfusions as a key risk factor.

Cite This Study

Al‐Naamani et al. (2025) studied this question.

synapsesocial.com/papers/68c23abeb210217d64782149 https://doi.org/10.20944/preprints202509.0187.v1

View Full Paper

Ask AI

Bookmark

Implication

Cross-sectional study shows 5.63% seroprevalence of hepatitis D in chronic hepatitis B patients, highlighting blood transfusions as a key risk factor.

The Seroprevalence, Risk Factors, and Clinical Profile of Hepatitis D in Patients with Chronic Hepatitis B in Oman: A Multicenter Cross-Sectional Study

Key Points

Discussion

Implication

Cite This Study

The Seroprevalence, Risk Factors, and Clinical Profile of Hepatitis D in Patients with Chronic Hepatitis B in Oman: A Multicenter Cross-Sectional Study

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider